Abbott Laboratories
ABTNYSEHealthcare● Active
$90.50
$-0.57(-0.63%)
Market Cap$157.6B
P/E Ratio—
52W High$139.06
52W Low$81.97
Abbott Laboratories (ABT) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABT · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $8.94B | $7.97B | $7.28B | $10.17B | $10.25B |
| Net Receivables | $7.93B | $6.92B | $6.57B | $6.22B | $6.49B |
| Inventory | $6.49B | $6.19B | $6.57B | $6.17B | $5.16B |
| Total Current Assets | $26.00B | $23.66B | $22.67B | $25.22B | $24.24B |
| PP&E Net | $12.94B | $11.73B | $11.28B | $10.28B | $10.11B |
| Goodwill | $24.04B | $23.11B | $23.68B | $22.80B | $23.23B |
| Intangible Assets | $5.53B | $6.65B | $8.81B | $10.45B | $12.74B |
| Total Assets | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B |
| Liabilities | |||||
| Short-Term Debt | $3.31B | $1.75B | $1.32B | $2.48B | $1.00B |
| Accounts Payable | $4.24B | $4.20B | $4.29B | $4.61B | $4.41B |
| Total Current Liabilities | $16.50B | $14.16B | $13.84B | $15.49B | $13.11B |
| Long-Term Debt | $10.83B | $12.63B | $13.60B | $14.52B | $17.30B |
| Total Liabilities | $33.94B | $33.51B | $34.39B | $37.53B | $39.17B |
| Stockholders Equity | |||||
| Retained Earnings | $49.78B | $47.26B | $37.55B | $35.26B | $31.53B |
| Total Stockholders Equity | $52.13B | $47.66B | $38.60B | $36.69B | $35.80B |
| Total Liab & Equity(computed) | $86.07B | $81.18B | $72.99B | $74.22B | $74.97B |
| Debt Summary | |||||
| Total Debt | $15.07B | $15.28B | $15.87B | $17.95B | $19.25B |
| Net Debt | $6.54B | $7.66B | $8.98B | $8.06B | $9.45B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Abbott Laboratories data
About Abbott Laboratories (ABT) Balance Sheet
Abbott Laboratories (ABT) balance sheet shows total assets of $86.71B with cash of $8.94B. Total liabilities are $33.94B, total debt $15.07B, and stockholders equity $52.13B.
Frequently asked questions
ABT · 4 questionsAbbott Laboratories has total debt of $15.07B with net debt of $6.54B.
ABT total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10